UNSPSC 51281655: Micronomicin sulfate

This classification denotes an aminoglycoside antibiotic with the molecular formula 2C20H41N5O7.5H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 09H5UKQ7TZ, chemically known as d-streptamine, o-2-amino-2,3,4,6-tetradeoxy-6-(methylamino)-.alpha.-d-erythro-hexopyranosyl-(1-4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-.beta.-l-arabinopyranosyl-(1-6))-2-deoxy-, sulfate (salt), but more generally known as micronomicin sulfate, which bears US NIH Compound Identifier 171808.

European Medicines Agency schedules micronomicin sulfate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08945MIG. Most nations, for tariff purposes, schedule micronomicin sulfate under HS 29419000. SMILES:.

UNSPSC 51281655 Micronomicin sulfate is a Commodity code that covers a specific antibiotic pharmaceutical product, yet the recent state and local opportunities tagged under it reflect broader pharmaceutical procurement activity rather than this narrow drug alone. State and local health departments and counties use codes in this family to source antibiotics and other pharmaceutical products through cooperative purchasing consortia, piggyback contracts, and competitive bidding processes. The issuing bodies are typically state health departments and county health or community health agencies seeking to build inventory or meet recurring clinical and public-health demand. Work solicited under or near this code includes warehouse supply contracts for multiple pharmaceutical SKUs and procurement of public-health medications such as naloxone.

Recent activity appears concentrated in Florida and Illinois. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026 through the MMCAP Infuse consortium for Doxycycline Hyclate and Ciprofloxacin Hydrochloride over a three-year term with renewal options. Seminole County, Florida issued an IFB on June 30, 2026 (with a July 26, 2023 response deadline noted in the record) seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the county's community health building; the procurement included E-Verify compliance, drug-free workplace certification, and standard insurance requirements, with potential FEMA funding triggering federal environmental compliance. Neither recent opportunity directly addresses micronomicin sulfate, suggesting the code may see limited state and local activity or that opportunities are being tagged under broader pharmaceutical family codes rather than this specific Commodity.